Farmakoekonomika
SJR0.159
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | — | — | 0.159 | Q4 | 18.8% | |
| 2024 | — | — | 0.143 | Q4 | 18.1% | |
| 2023 | — | — | 0.162 | Q4 | 27.7% | |
| 2022 | — | — | 0.149 | Q4 | 28.3% | |
| 2021 | — | — | 0.155 | Q4 | 31.4% | |
| 2020 | — | — | 0.177 | Q4 | 30.2% | |
| 2019 | — | — | — | 0.0% | ||
Impact history
Annual SJR and Impact Factor trend.
SJR
Journal record
eISSN
2070-4909
ISSN
2070-4933
region
Eastern Europe
coverage
2017-2025